Congratulations to Théo Imler for his graduation as MSc. in Life Sciences and Engineering by EPFL!Théo did an excellent defense of his MSc. Thesis project, focused on developing and characterizing a novel cellular model for modeling Vascular Leak Syndrome on the AlveoliX Lung-On-Chip.Congrats on this great achievement!
MoreIn this new work by Olivier Guenat and Thomas Geiser together with Francois Berthiaume, the possibilities of extracting clinically relevant tissue-level information from Organ on Chip devices are set into perspective. Check this enlightening work in “Clinically Relevant Tissue Scale Responses as New Readouts from Organs-on-a-Chip for Precision Medicine”. Learn more
MoreAfter having completed the phase of Core Coaching, we have been successfully certified as a company “ready for sustainable growth” by Innosuisse, The Swiss Innovation Agency. We are excited about the new growth phase ahead of us.
MoreAlveoliX innovative contribution for lung-on-chip based inhalation assays has been published in “Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline” in collaboration with the Israel Institute of Technology, ARTORG Center and Helmholtz Institute for Pharmaceutical Research Saarland. Learn more
MoreThe Swiss Institute for Translation and Entrepreneurship in Medicine opens its doors to the public on August 30th to share the spirit of innovation and translational medicine. Join AlveoliX and all new units at SITEM, who will be exposing their cutting-edge technology to make patients life better.
MoreIn the course of this continuous growth, the Board of Directors has decided to further strengthen the positive momentum with a concentrated charge of expertise. Dr. Janick Stucki, AlveoliX’s Chief Technical Officer, and Dr. Nina Hobi, AlveoliX’s Chief Scientific Officer, have been appointed as the company’s new Co-CEOs. Stucki and Hobi succeed Prof. Olivier Guenat,…
MoreEUROSTARS is a joint initiative co-funded from the national budgets of 36 Eurostars and by the European Union through Horizon 2020. In the 2014-2020 period, the program has a total public budget of €1.14 billion.
MoreAs part of her Master in Life Sciences & Technology at EPFL, Ms. Raggi’s work consisted in reproducing a fatal pulmonary disease, acute lung injury, in vitro. Her great job with the lung-on-chip technology has been recognised by EPFL as the best project within her master program. Congratulations Giulia!
MoreThe AlveoliX Lung-on-a Chip developed with the ARTORG Center of the University of Bern has just been published in Nature Scientific Reports.
More